RA Capital Management - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.

Quarter-by-quarter ownership
RA Capital Management ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$60,378,000
+8.0%
734,343
+92.7%
1.32%
+33.7%
Q4 2021$55,896,000
+346.3%
381,046
-42.0%
0.98%
+9.7%
Q1 2014$12,525,000
+14.7%
656,7670.0%0.90%
-29.4%
Q4 2013$10,922,000
+30.7%
656,767
+19.0%
1.27%
+45.9%
Q3 2013$8,359,000551,7230.87%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$116,595,21681.37%
ORACLE INVESTMENT MANAGEMENT INC 201,400$7,488,0527.25%
Paradigm Biocapital Advisors LP 1,396,779$51,932,2434.92%
Octagon Capital Advisors LP 750,000$27,885,0004.01%
Boxer Capital, LLC 2,000,000$74,3603.65%
Artal Group S.A. 1,537,709$57,1723.40%
Avoro Capital Advisors LLC 5,555,555$206,555,5353.06%
RTW INVESTMENTS, LP 3,643,114$135,450,9792.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 244,000$9,071,9202.53%
Kynam Capital Management, LP 499,853$18,584,5352.40%
View complete list of MIRATI THERAPEUTICS INC shareholders